Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Investigating brain mechanisms for cognitive assessment and rehabilitation in cognitive decline

Official title: Neural Mechanisms of Cognitive Assessment and Rehabilitation for Cognitive Decline

Run by National Research Center for Rehabilitation Technical Aids · NCT05014893 · Data updated 2026-11-12

This study is testing different ways to improve thinking skills in people with mild cognitive decline by looking at brain activity and trying out activities like training, exercise, and games.

More Aging trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorNational Research Center for Rehabilitation Technical Aids
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedAugust 6, 2021
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMay 22, 2025
Trial IDNCT05014893 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with subjective cognitive decline, mild cognitive impairment, or those with normal cognitive function who can walk at least a block.

Probably not a fit

Patients with a clinical diagnosis of dementia or those unable to follow the study protocol may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the neural mechanisms underlying cognitive decline and evaluates various cognitive assessment methods for individuals experiencing mild cognitive dysfunction. It employs functional and structural MRI and EEG to analyze brain activity and structure in participants from different cities. The study also tests multi-modal targeted interventions, including cognitive training, exercise, and games, aimed at improving and restoring cognitive function in affected individuals.

Why it matters

Potential benefit: If successful, this study could lead to effective interventions that enhance cognitive function in individuals with mild cognitive impairment and subjective cognitive decline.

How similar studies have gone: Other studies have shown promise in using cognitive training and rehabilitation approaches, suggesting potential success for this study's methodology.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults being able to walk at least a block, and
* Adults with subjective cognitive decline (SCD), or
* Adults with mild cognitive impairment (MCI), or
* Adults with normal cognitive function

Exclusion Criteria:

* Clinical diagnosis of dementia
* Adults who cannot follow the protocal

Where it's running

  • National Research Center for Rehabilitation Technical Aids
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Pengxu Wei — National Research Center for Rehabilitation Technical Aids
  • Study coordinator: Ying Wang
  • Email: CARM_AD@aliyun.com
  • Phone: 1058122921

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Aging Brain Health Initiative in Fujian

    This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.

    Recruiting at 4 sites Fujian Medical University Union Hospital · Fushun, Fujian and 3 other locations · NCT07891429

  • Digital STEADI: A home-based digital fall prevention program for older adults

    A home-based digital program using AI-driven conversational agents tests if a guided fall-prevention exercise plan can reduce fall risk for older adults with mild cognitive impairment living independently.

    Recruiting Phase 1/2 Friendi.fi Corporation · Atlanta, Georgia · NCT07852650

  • Digital tools to predict Alzheimer's biology from risk factors

    This study tests a digital, AI-based tool that analyzes modifiable and non-modifiable risk factors to see if it can predict biological changes linked to Alzheimer's disease in adults with MCI or SCD.

    Recruiting at 2 sites IRCCS Centro San Giovanni di Dio Fatebenefratelli · Brescia, BS and 1 other locations · NCT07731191

  • Online positive psychology program to support thinking and brain health in early memory changes

    This study will test whether an online positive psychology program can improve thinking, brain function, and wellbeing in older adults with early memory problems (Subjective Cognitive Decline or Mild Cognitive Impairment).

    Recruiting Aristotle University Of Thessaloniki · Thessaloniki · NCT07289061

  • Personalized digital training for cognitive fitness in people with mild cognitive impairment

    This study tests whether a personalized home-based digital program (RICORDO) helps people aged 50 and older with mild cognitive impairment or subjective cognitive decline manage their health and daily life better than a paper-and-video education program.

    Recruiting at 2 sites University of Modena and Reggio Emilia · Modena, Reggio Nell'Emilia (RE) and 1 other locations · NCT07286448

  • NPC-1 (parthenolide and ipriflavone) for Alzheimer's blood biomarkers

    This trial will test whether taking NPC-1 (a combination of parthenolide and ipriflavone) is safe, well tolerated, and changes blood tests linked to Alzheimer's in adults 55+ with subjective cognitive decline, mild cognitive impairment, or mild Alzheimer's who have biomarker evidence of disease.

    Recruiting Phase 2 Massachusetts General Hospital · Boston, Massachusetts · NCT07236190

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.